Verhaegen J - Search Results

1

Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly population and implications for vaccine use.

Flamaing J, Verhaegen J, Peetermans WE. Flamaing J, et al. Among authors: verhaegen j. J Antimicrob Chemother. 2002 Jul;50(1):43-50. doi: 10.1093/jac/dkf086. J Antimicrob Chemother. 2002. PMID: 12096005

2

Consumption patterns and in vitro resistance of Streptococcus pneumoniae to fluoroquinolones.

Simoens S, Verhaegen J, van Bleyenbergh P, Peetermans WE, Decramer M. Simoens S, et al. Among authors: verhaegen j. Antimicrob Agents Chemother. 2011 Jun;55(6):3051-3. doi: 10.1128/AAC.00019-11. Epub 2011 Apr 4. Antimicrob Agents Chemother. 2011. PMID: 21464243 Free PMC article.

3

Trends in serotype prevalence in invasive pneumococcal disease before and after infant pneumococcal vaccination in Belgium, 2002-2010.

Liesenborghs L, Verhaegen J, Peetermans WE, Vandeven J, Flamaing J. Liesenborghs L, et al. Among authors: verhaegen j. Vaccine. 2013 Mar 1;31(11):1529-34. doi: 10.1016/j.vaccine.2012.11.103. Epub 2012 Dec 20. Vaccine. 2013. PMID: 23261044

4

The impact of childhood 13-valent pneumococcal conjugate vaccination on overall invasive pneumococcal disease, including the oldest old.

Henckaerts L, Desmet S, Schalck N, Lagrou K, Verhaegen J, Peetermans WE, Flamaing J. Henckaerts L, et al. Among authors: verhaegen j. Acta Clin Belg. 2021 Aug;76(4):272-279. doi: 10.1080/17843286.2020.1721131. Epub 2020 Jan 30. Acta Clin Belg. 2021. PMID: 32000622

5

Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.

Flamaing J, Verhaegen J, Vandeven J, Verbiest N, Peetermans WE. Flamaing J, et al. Among authors: verhaegen j. J Antimicrob Chemother. 2008 Jan;61(1):143-9. doi: 10.1093/jac/dkm435. Epub 2007 Nov 13. J Antimicrob Chemother. 2008. PMID: 17999974

6

Increase in penicillin resistance rates in Belgium due to clonal spread of a penicillin-resistant 23F Streptococcus pneumoniae strain.

Hoefnagels-Schuermans A, Van Eldere J, Van Lierde S, Verbist L, Verhaegen J, Peetermans WE. Hoefnagels-Schuermans A, et al. Among authors: verhaegen j. Eur J Clin Microbiol Infect Dis. 1999 Feb;18(2):120-5. doi: 10.1007/s100960050239. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10219576

7

Macrolide resistance in Belgian Streptococcus pneumoniae.

Lagrou K, Peetermans WE, Verhaegen J, Van Lierde S, Verbist L, Van Eldere J. Lagrou K, et al. Among authors: verhaegen j. J Antimicrob Chemother. 2000 Jan;45(1):119-21. doi: 10.1093/jac/45.1.119. J Antimicrob Chemother. 2000. PMID: 10629023

8

Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in vitro.

Lagrou K, Peetermans WE, Jorissen M, Verhaegen J, Van Damme J, Van Eldere J. Lagrou K, et al. Among authors: verhaegen j. J Antimicrob Chemother. 2000 Nov;46(5):717-23. doi: 10.1093/jac/46.5.717. J Antimicrob Chemother. 2000. PMID: 11062190

9

Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams.

Van Kerkhoven D, Peetermans WE, Verbist L, Verhaegen J. Van Kerkhoven D, et al. Among authors: verhaegen j. J Antimicrob Chemother. 2003 Mar;51(3):691-6. doi: 10.1093/jac/dkg116. J Antimicrob Chemother. 2003. PMID: 12615872

10

Antibiotic susceptibility and serotype distribution of 240 Streptococcus pneumoniae causing meningitis in Belgium 1997-2000.

Verhaegen J, Vandecasteele SJ, Vandeven J, Verbiest N, Lagrou K, Peetermans WE. Verhaegen J, et al. Acta Clin Belg. 2003 Jan-Feb;58(1):19-26. doi: 10.1179/acb.2003.58.1.003. Acta Clin Belg. 2003. PMID: 12723258

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters